🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and efficacy of simmitinib plus irinotecan liposome ...
Status
Unknown
Location
Harbin Medical University Cancer Hospital
Start Date
2024-03-15
Trial ID
NCT06512428
Treatments Being Tested
This is an open label, multi-center, phase I study of oral Simmitinib in su...
Status
Unknown
Location
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Start Date
2020-06-08
Trial ID
NCT04058587
Treatments Being Tested
This study is divided into two parts: Cohort 1 and Cohort 2. Cohort 1 inclu...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-26
Trial ID
NCT06577376
Treatments Being Tested
This is an open-label Phase I/II trial of simmitinib plus SG001 in patients...
Status
Not Yet Recruiting
Location
Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2024-01-30
Trial ID
NCT06132217
Treatments Being Tested
To evaluate the overall survival of simmitinib versus investigator's choice...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-31
Trial ID
NCT06656091
Treatments Being Tested